ROCHE DIAGNOSTICS ASIA PACIFIC PTE LTD
Country of registration | Singapore |
Registration number | 199803381W |
Local SIC | |
Incorporation date | 11 Jul 1998 |
Company age | 27 years 10 months |
Official entity type | Private Limited Company |
No. of officers | 32 |
Contact
8 KALLANG AVENUE, #10-01/09, APERIA, Singapore 339509
This is the legal entity page of ROCHE DIAGNOSTICS ASIA PACIFIC PTE LTD. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- ROCHEView MoreSwitzerlandRoche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit our community guidelines here: #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
Fiscal/Budgeting Period | October - December |
Auditor | KPMG LLP |
Revenue | 251m - 500m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | SGD 20,400,000 |
- A PLUS INTEGRATED MARKETING PTE. LTD.

- A.B.T. MEDICAL PRODUCTS PTE LTD

- A.M. ERICHSEN LABTECH (SOUTH EAST ASIA) PTE LTD

- A.V.N. MOTOR WORK COMPANY LIMITED

- A1 QUALITY ENTERPRISES (S) PTE. LTD.

- AAMRO GLOBAL PTE. LTD.

- ABBY SCIENTIFIC PTE. LTD.

- ABEX GLOBAL HEALTHCARE (S) PTE. LTD.

- ABSOLUTE MS (S) PTE. LTD.

- ABSORTECH ASIA PACIFIC PTE. LTD.

Frequently Asked Questions (FAQ)
- What is the address of ROCHE DIAGNOSTICS ASIA PACIFIC PTE LTD?
- Where is ROCHE DIAGNOSTICS ASIA PACIFIC PTE LTD's headquarter?
- What is ROCHE DIAGNOSTICS ASIA PACIFIC PTE LTD's contact number?
- What ROCHE DIAGNOSTICS ASIA PACIFIC PTE LTD's spending power?
- Does ROCHE DIAGNOSTICS ASIA PACIFIC PTE LTD have a presence in the domain it operates in?
